Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Oldham

Showing results (511-520 of 567) with videos related to

Pageof 57
Sort By:
American Journal of Respiratory and Critical Care Medicine|July 18, 2025
A Quantitative Imaging Measure of Progressive Pulmonary FibrosisJennifer M Wang, Ayodeji Adegunsoye, Janelle Vu Pugashetti, et al.
American Journal of Respiratory and Critical Care Medicine|June 24, 2024
Molecular Endotypes of Idiopathic Pulmonary Fibrosis: A Latent Class Analysis of Two Multicenter Observational CohortsManoj V Maddali, Andrew R Moore, Pratik Sinha, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|January 16, 2024
Fatty acid metabolism promotes TRPV4 activity in lung microvascular endothelial cells in pulmonary arterial hypertensionNicolas Philip, Xin Yun, Hongyang Pi, et al.
American Journal of Respiratory and Critical Care Medicine|February 4, 2017
Microbes Are Associated with Host Innate Immune Response in Idiopathic Pulmonary FibrosisYong Huang, Shwu-Fan Ma, Milena S Espindola, et al.
American Journal of Respiratory and Critical Care Medicine|March 14, 2024
The Role of Inflammation and Fibrosis in Interstitial Lung Disease Treatment DecisionsJuergen Behr, Margaret L Salisbury, Simon L F Walsh, et al.
Comprehensive Physiology|May 15, 2026
Exploring the Lung-Liver Axis in Pulmonary Arterial HypertensionNavneet Singh, Jordan Lawson, Ashok Ragavendran, et al.
American Journal of Respiratory and Critical Care Medicine|October 17, 2023
Proteomic Biomarkers of Survival in Idiopathic Pulmonary FibrosisJustin M Oldham, Yong Huang, Swaraj Bose, et al.
American Journal of Respiratory and Critical Care Medicine|June 6, 2024
Biological Age, Chronological Age, and Survival in Pulmonary Fibrosis: A Causal Mediation AnalysisJanelle Vu Pugashetti, John S Kim, Swaraj Bose, et al.
JCI Insight|May 4, 2021
Antibody-mediated depletion of CCR10+EphA3+ cells ameliorates fibrosis in IPFMiriam S Hohmann, David M Habiel, Milena S Espindola, et al.
The Lancet. Digital Health|November 4, 2022
Forced vital capacity trajectories in patients with idiopathic pulmonary fibrosis: a secondary analysis of a multicentre, prospective, observational cohortHernan P Fainberg, Justin M Oldham, Philip L Molyneau, et al.
Pageof 57

Showing results (511-520 of 567) with videos related to

Sort By:
Pageof 57
American Journal of Respiratory and Critical Care Medicine|July 18, 2025
A Quantitative Imaging Measure of Progressive Pulmonary FibrosisJennifer M Wang, Ayodeji Adegunsoye, Janelle Vu Pugashetti, et al.
American Journal of Respiratory and Critical Care Medicine|June 24, 2024
Molecular Endotypes of Idiopathic Pulmonary Fibrosis: A Latent Class Analysis of Two Multicenter Observational CohortsManoj V Maddali, Andrew R Moore, Pratik Sinha, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|January 16, 2024
Fatty acid metabolism promotes TRPV4 activity in lung microvascular endothelial cells in pulmonary arterial hypertensionNicolas Philip, Xin Yun, Hongyang Pi, et al.
American Journal of Respiratory and Critical Care Medicine|February 4, 2017
Microbes Are Associated with Host Innate Immune Response in Idiopathic Pulmonary FibrosisYong Huang, Shwu-Fan Ma, Milena S Espindola, et al.
American Journal of Respiratory and Critical Care Medicine|March 14, 2024
The Role of Inflammation and Fibrosis in Interstitial Lung Disease Treatment DecisionsJuergen Behr, Margaret L Salisbury, Simon L F Walsh, et al.
Comprehensive Physiology|May 15, 2026
Exploring the Lung-Liver Axis in Pulmonary Arterial HypertensionNavneet Singh, Jordan Lawson, Ashok Ragavendran, et al.
American Journal of Respiratory and Critical Care Medicine|October 17, 2023
Proteomic Biomarkers of Survival in Idiopathic Pulmonary FibrosisJustin M Oldham, Yong Huang, Swaraj Bose, et al.
American Journal of Respiratory and Critical Care Medicine|June 6, 2024
Biological Age, Chronological Age, and Survival in Pulmonary Fibrosis: A Causal Mediation AnalysisJanelle Vu Pugashetti, John S Kim, Swaraj Bose, et al.
JCI Insight|May 4, 2021
Antibody-mediated depletion of CCR10+EphA3+ cells ameliorates fibrosis in IPFMiriam S Hohmann, David M Habiel, Milena S Espindola, et al.
The Lancet. Digital Health|November 4, 2022
Forced vital capacity trajectories in patients with idiopathic pulmonary fibrosis: a secondary analysis of a multicentre, prospective, observational cohortHernan P Fainberg, Justin M Oldham, Philip L Molyneau, et al.
Pageof 57